PLX
Protalix Biotherapeutics
Description:
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in Israel, Brazil, the rest of Latin America and internationally. The company is headquartered in Karmiel, Israel.
Industry:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address:
2 SNUNIT ST, SCIENCE PARK, POB 455, CARMIEL, IL
Fiscal year end:
December
Market capitalization:
$118 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
-91%
How much will you get:
$89
Prices dates:
31-07-2015: $16.40 and 31-07-2025: $1.46